Lee's Pharmaceutical Holdings Limited provided unaudited earnings guidance for the six months ended June 30, 2019. For the period, the Group is expected to record an net profit attributable to the shareholders of between HKD 31.44 million and HKD 44.02 million, representing a decrease of approximately 65% to 75%, as compared with approximately HKD 125.77 million recorded for the six months ended 30 June 2018.